Event January 12–15, 2026

BCG Alongside the 2026 J.P. Morgan Healthcare Conference

BCG’s top health care experts will be on the ground alongside the J.P. Morgan Healthcare Conference, January 12–15, 2026, to explore how scientific breakthroughs are fueling innovation and reshaping the industry.

The J.P. Morgan Healthcare Conference is the largest health care investment symposium in the industry. Each year, it brings together business leaders, health care executives, investors, policymakers, and other leaders to explore how scientific advances are changing the business of care around the world. Alongside the conference, BCG will bring together experts to discuss key themes around innovation, including digital and AI. Explore how new technologies are helping companies get new therapies to market faster, pushing care out of traditional settings and into the hands of patients, and creating new opportunities for companies and investors.

Highlights from JP Morgan 2026

Clinical-Grade AI Drives New Models of Care

Munjal Shah of Hippocratic AI explains how AI enables innovative approaches to prevention, follow-up, and patient access.

Clinical-Grade AI Drives New Models of Care

Clinical-Grade AI Drives New Models of Care

Munjal Shah of Hippocratic AI explains how AI enables innovative approaches to prevention, follow-up, and patient access.
Reimagining Access with Long-Acting Treatments

Reimagining Access with Long-Acting Treatments

Christophe Douat, CEO of Medincell, explains how long-acting injectables can improve adherence, lower costs, and expand access to care in low- and middle-income countries.
Partnering to Unlock AI’s Next Wave in Health Care

Partnering to Unlock AI’s Next Wave in Health Care

Munjal Shah of Hippocratic AI, and BCG’s Ashkan Afkhami discuss how BCG and Hippocratic's collaboration aims to move generative AI from experimentation to scaled impact across life sciences and health care.
When Neurological Disease Outpaces the Care Model

When Neurological Disease Outpaces the Care Model

As stroke and dementia rates rise worldwide, Moleac CEO David Picard discusses why existing care pathways leave too many patients behind—and where science can still change outcomes.
Value Creation as the Test for AI in Health Care

Value Creation as the Test for AI in Health Care

For AI success, health care companies need to be on board with the value creation that the technology can achieve, says BCG’s Sabrina Kristic.
How Actionable Hormone Data Can Transform Women’s Health

How Actionable Hormone Data Can Transform Women’s Health
When Health Care Companies Can Skip the AI Pilot

When Health Care Companies Can Skip the AI Pilot

BCG’s Jazz Tobaccowalla explains why leaders should stop experimenting with AI use cases that already work and focus on scaling value through people and change.
How AI Is Expanding Access and Efficiency in Medical Imaging

How AI Is Expanding Access and Efficiency in Medical Imaging

GE Healthcare’s Roland Rott explains how AI is helping health care systems see more patients, address workforce shortages, and deliver faster, more confident care.
What Creates Lasting Advantage in AI-Driven Health Care

What Creates Lasting Advantage in AI-Driven Health Care

Health Business Group’s David Williams explains why AI creates lasting value only when it reinforces existing advantages—such as data, access, and operating models—rather than standing on its own.

Bringing Our Expertise to J.P. Morgan Healthcare Conference 2026

Meet Our Experts

Our Latest Thinking

Frequently Asked Questions

Expand All

What is the J.P. Morgan Healthcare Conference?

When is the J.P. Morgan Healthcare Conference?

Where is the J.P. Morgan Healthcare Conference?

Explore Related Services